{"id":195467,"date":"2026-08-11T12:49:46","date_gmt":"2026-08-11T07:19:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=195467"},"modified":"2026-08-11T12:49:47","modified_gmt":"2026-08-11T07:19:47","slug":"ind-swift-laboratories-q1-results-fy27-pat-24-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/","title":{"rendered":"Ind-Swift Laboratories Q1 FY27 Results: Revenue Rs 191 Cr, PAT Rs 24 Cr and Key Highlights"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Ind-Swift Laboratories Q1 FY27 results declared August 10, 2026. Revenue Rs 191 Cr (+25.35% YoY). PAT Rs 24 Cr (+184.10% YoY). CMP Rs 237.24 (+3.87%).<\/em><\/p>\n<p>Ind-Swift Laboratories Q1 FY27 results were declared on August 10, 2026 on a consolidated basis. Revenue expanded +25.35% YoY to Rs 191 Cr from Rs 152 Cr in Q1 FY26. The broader <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index reflected mixed sentiment during the quarter.<\/p>\n<p>Operating profit stood at Rs 25 Cr (+940.37% YoY). PAT came in at Rs 24 Cr (+184.10% YoY), reflecting the key financial metrics of Ind-Swift Laboratories Q1 FY27 results.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=ind-swift-laborato-q1-fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Ind-Swift_Laboratories_Q1_FY27_Financial_Highlights\" title=\"Ind-Swift Laboratories Q1 FY27 Financial Highlights\">Ind-Swift Laboratories Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Ind-Swift_Laboratories_Q1_FY27_Performance_Analysis\" title=\"Ind-Swift Laboratories Q1 FY27 Performance Analysis\">Ind-Swift Laboratories Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Key_Business_Factors_in_Ind-Swift_Laboratories_Q1_FY27_Results\" title=\"Key Business Factors in Ind-Swift Laboratories Q1 FY27 Results\">Key Business Factors in Ind-Swift Laboratories Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Revenue_Expansion_in_Q1_FY27\" title=\"Revenue Expansion in Q1 FY27\">Revenue Expansion in Q1 FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Operating_Margin_Performance\" title=\"Operating Margin Performance\">Operating Margin Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#PAT_Trajectory_and_Profitability\" title=\"PAT Trajectory and Profitability\">PAT Trajectory and Profitability<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#FY27_Outlook_for_Ind-Swift_Laboratories\" title=\"FY27 Outlook for Ind-Swift Laboratories\">FY27 Outlook for Ind-Swift Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Ind-Swift_Laboratories_Stock_Performance_After_Q1_FY27_Results\" title=\"Ind-Swift Laboratories Stock Performance After Q1 FY27 Results\">Ind-Swift Laboratories Stock Performance After Q1 FY27 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Key_Risks_for_Ind-Swift_Laboratories\" title=\"Key Risks for Ind-Swift Laboratories\">Key Risks for Ind-Swift Laboratories<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Sector-Specific_Risks\" title=\"Sector-Specific Risks\">Sector-Specific Risks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Valuation_and_Earnings_Risk\" title=\"Valuation and Earnings Risk\">Valuation and Earnings Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Operational_and_Financial_Risk\" title=\"Operational and Financial Risk\">Operational and Financial Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Frequently_Asked_Questions_on_Ind-Swift_Laboratories_Q1_FY27_Results\" title=\"Frequently Asked Questions on Ind-Swift Laboratories Q1 FY27 Results\">Frequently Asked Questions on Ind-Swift Laboratories Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#When_were_Ind-Swift_Laboratories_Q1_FY27_results_declared\" title=\"When were Ind-Swift Laboratories Q1 FY27 results declared?\">When were Ind-Swift Laboratories Q1 FY27 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#What_was_Ind-Swift_Laboratories_revenue_in_Q1_FY27\" title=\"What was Ind-Swift Laboratories revenue in Q1 FY27?\">What was Ind-Swift Laboratories revenue in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#What_was_Ind-Swift_Laboratories_PAT_in_Q1_FY27\" title=\"What was Ind-Swift Laboratories PAT in Q1 FY27?\">What was Ind-Swift Laboratories PAT in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#Did_Ind-Swift_Laboratories_declare_a_dividend_in_Q1_FY27\" title=\"Did Ind-Swift Laboratories declare a dividend in Q1 FY27?\">Did Ind-Swift Laboratories declare a dividend in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#What_is_the_FY27_outlook_for_Ind-Swift_Laboratories\" title=\"What is the FY27 outlook for Ind-Swift Laboratories?\">What is the FY27 outlook for Ind-Swift Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/ind-swift-laboratories-q1-results-fy27-pat-24-crore\/#How_did_Ind-Swift_Laboratories_stock_react_to_Q1_FY27_results\" title=\"How did Ind-Swift Laboratories stock react to Q1 FY27 results?\">How did Ind-Swift Laboratories stock react to Q1 FY27 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Q1_FY27_Financial_Highlights\"><\/span><strong>Ind-Swift Laboratories Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px;\">\n<thead>\n<tr style=\"background: #0A0E1A; color: #fff;\">\n<th style=\"padding: 10px; text-align: left; border: 1px solid #DDD;\">Metric<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">Q1 FY27 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">Q1 FY26 (Rs Cr)<\/th>\n<th style=\"padding: 10px; text-align: center; border: 1px solid #DDD;\">YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Ind-Swift Laboratories Revenue<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">191<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">152<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+25.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Operating Profit<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">25<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">-3.00<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+940.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Net Profit (PAT)<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">24<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\">8.00<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD; color: green;\">+184.10%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border: 1px solid #DDD;\">Reporting Basis<\/td>\n<td style=\"padding: 8px; text-align: center; border: 1px solid #DDD;\" colspan=\"3\">Consolidated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Q1_FY27_Performance_Analysis\"><\/span><strong>Ind-Swift Laboratories Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data on This Stock<\/strong><\/a><\/p>\n<p>Ind-Swift Laboratories Q1 FY27 results reflect exceptional fundamentals. Revenue momentum were evident with the top line reaching Rs 191 Cr for the April to June 2026 quarter.<\/p>\n<p>Operating profit expanded +940.37% YoY. PAT of Rs 24 Cr reflects +184.10% YoY movement. Investors tracking Ind-Swift Laboratories Q1 FY27 results will note these as key FY27 milestones.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Ind-Swift_Laboratories_Q1_FY27_Results\"><\/span><strong>Key Business Factors in Ind-Swift Laboratories Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_Expansion_in_Q1_FY27\"><\/span><strong>Revenue Expansion in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Ind-Swift Laboratories Q1 FY27 results show revenue expanding +25.35% YoY to Rs 191 Cr from Rs 152 Cr in Q1 FY26. Volume-led growth and market share gains in the Pharmaceuticals segment drove the uptick.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operating_Margin_Performance\"><\/span><strong>Operating Margin Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating profit in Ind-Swift Laboratories Q1 FY27 results stood at Rs 25 Cr (+940.37% YoY). Better cost absorption and product mix improvement contributed to the operating performance.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"PAT_Trajectory_and_Profitability\"><\/span><strong>PAT Trajectory and Profitability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>PAT in Ind-Swift Laboratories Q1 FY27 results was Rs 24 Cr (+184.10% YoY), reflecting the company&#8217;s improving financial health.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend was declared alongside Ind-Swift Laboratories Q1 FY27 results. Earnings are being channelled toward operational reinvestment and working capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_for_Ind-Swift_Laboratories\"><\/span><strong>FY27 Outlook for Ind-Swift Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ind-Swift Laboratories is positioned to sustain growth momentum through FY27, backed by order visibility, operational improvements, and sector tailwinds in the pharmaceuticals space. Investors tracking Ind-Swift Laboratories Q1 FY27 results should consult a SEBI-registered financial advisor before making decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ind-Swift_Laboratories_Stock_Performance_After_Q1_FY27_Results\"><\/span><strong>Ind-Swift Laboratories Stock Performance After Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Ind-Swift Laboratories live price and get daily stock recommendations.<\/em><\/p>\n<p>Ind-Swift Laboratories shares were trading higher at Rs 237.24 (+3.87%) on August 10, 2026, reflecting investor sentiment on Ind-Swift Laboratories Q1 FY27 results and the near-term sector outlook. The CMP of Rs 237.24 on the results date reflects broader sentiment toward the pharmaceuticals space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Ind-Swift_Laboratories\"><\/span><strong>Key Risks for Ind-Swift Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Sector-Specific_Risks\"><\/span><strong>Sector-Specific Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>USFDA regulatory actions, generic pricing pressure, and API cost inflation remain core risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_and_Earnings_Risk\"><\/span><strong>Valuation and Earnings Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Valuation risk remains if quarterly growth fails to sustain over the next two to three quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Operational_and_Financial_Risk\"><\/span><strong>Operational and Financial Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ind-Swift Laboratories Q1 FY27 results reflect exceptional performance with revenue at Rs 191 Cr and PAT at Rs 24 Cr on a Consolidated basis. Sector tailwinds and operational discipline will shape the FY27 trajectory. Investors should review management commentary before taking any position.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Ind-Swift_Laboratories_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Ind-Swift Laboratories Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Ind-Swift_Laboratories_Q1_FY27_results_declared\"><\/span><strong>When were Ind-Swift Laboratories Q1 FY27 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ind-Swift Laboratories Q1 FY27 results were declared on August 10, 2026, covering the April\u2013June 2026 quarter on a Consolidated basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Ind-Swift_Laboratories_revenue_in_Q1_FY27\"><\/span><strong>What was Ind-Swift Laboratories revenue in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue in Ind-Swift Laboratories Q1 FY27 results was Rs 191 Cr, +25.35% YoY from Rs 152 Cr in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Ind-Swift_Laboratories_PAT_in_Q1_FY27\"><\/span><strong>What was Ind-Swift Laboratories PAT in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit in Ind-Swift Laboratories Q1 FY27 results was Rs 24 Cr (+184.10% YoY).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Ind-Swift_Laboratories_declare_a_dividend_in_Q1_FY27\"><\/span><strong>Did Ind-Swift Laboratories declare a dividend in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend was announced alongside Ind-Swift Laboratories Q1 FY27 results. Refer to official NSE and BSE announcements for future dividend updates.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Ind-Swift_Laboratories\"><\/span><strong>What is the FY27 outlook for Ind-Swift Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Management has guided revenue growth and margin improvement for FY27. Sector demand and execution will be key monitorables.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Ind-Swift_Laboratories_stock_react_to_Q1_FY27_results\"><\/span><strong>How did Ind-Swift Laboratories stock react to Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ind-Swift Laboratories shares were higher at Rs 237.24 (+3.87%) on August 10, 2026. Consult a SEBI-registered financial advisor before acting on price movements.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ind-Swift Laboratories Q1 FY27 results: Revenue Rs 191 Cr (+25.35% YoY), PAT Rs 24 Cr (+184.10% YoY). Key highlights, analysis and FY27 outlook.<\/p>\n","protected":false},"author":28,"featured_media":195466,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-195467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["195466"],"_edit_lock":["1786432790:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["73"],"rank_math_title":["Ind-Swift Laboratories Q1 FY27 Results: Revenue, PAT &amp; Key Highlight"],"rank_math_description":["Ind-Swift Laboratories Q1 FY27 results: Revenue Rs 191 Cr (+25.35% YoY), PAT Rs 24 Cr (+184.10% YoY). Key highlights, analysis and FY27 outlook."],"rank_math_focus_keyword":["Ind-Swift Laboratories Q1 FY27 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35860"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/ind-swift-laboratories-q1-results-fy27-pat-24-crore.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=195467"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195467\/revisions"}],"predecessor-version":[{"id":196560,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195467\/revisions\/196560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/195466"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=195467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=195467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=195467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}